REMI

Remedent, Inc. REMI

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode REMI CYPS DGEN NMRD EMGE UPH THCT NMXS TNGNQ VICA
6M -94.00 % -50.00 % 0.00 % 0.00 % -50.00 % -81.93 % 300.00 % 0.00 % 900.00 % 600.00 %
YTD -99.00 % -50.00 % 0.00 % 0.00 % -88.76 % 25.65 % -55.56 % -99.00 % 900.00 % 600.00 %
1Y -99.00 % -50.00 % 0.00 % -50.00 % -87.50 % -87.29 % -42.86 % -99.00 % 900.00 % 600.00 %
3Y -99.65 % -98.00 % 0.00 % -99.99 % -97.50 % -99.72 % -6.51 % -99.87 % 9 900.00 % -58.82 %
5Y -99.70 % -99.68 % -99.00 % -100.00 % -99.94 % -99.69 % -79.56 % -99.76 % 9 900.00 % -98.97 %
10Y -99.65 % -98.00 % -98.33 % -100.00 % -99.81 % -99.69 % -97.05 % -99.96 % 9 900.00 % -99.35 %
From the beginning -99.98 % -99.09 % -100.00 % -100.00 % -99.99 % -99.69 % -97.05 % -100.00 % 9 900.00 % -99.76 %

Dividend

Deltagen Inc.